Notably, the overexpression of circHMGB2 was found to inhibit the type 1 IFN response in NSCLC and enhance the exhaustion of cytotoxic T cells via the miR-181a-5p/CARM1 axis. Here, CARM1 is linked to non-small cell lung carcinoma.